The Future of drug delivery devices for subcutaneous administration
EducationalTHE NEXT FRONTIER IN COMBINATION PRODUCTS
2026-05-28 | 10:40 AM - 10:55 AM | TPD Room
Abstract
The future of drug delivery devices lies in their ability to address emerging healthcare trends, such as the rise in chronic diseases, the demand for personalized medicine, and the integration of digital health technologies. By combining advanced drug formulations, smart connected devices, and sustainable design practices, these combination products are poised to transform how treatments are developed, delivered, and experienced.
Innovative Treatments: Merck KGaA, Darmstadt, Germany is at the forefront of developing groundbreaking therapies for chronic, rare and complex conditions. By combining science, engineering and technology, the company develops a portfolio of drug delivery devices that offer precise, effective, and patient-friendly administration.
Connectivity in Medical Devices: Smart devices and digital health platforms integrated with drug delivery devices are revolutionizing patient care. These technologies enhance treatment adherence, enable remote monitoring, and provide actionable insights for personalized care, fostering collaboration between patients and healthcare providers and ultimately improving therapeutic outcomes.
Sustainability in Design and Manufacturing: As the industry and regulations will prioritize environmental responsibility, Merck KGaA is committed to sustainable practices. By adopting eco-friendly materials, minimizing waste, and optimizing manufacturing processes, the industry will ensure its innovative therapies align with global sustainability objectives.
By addressing these pillars, the presentation will a comprehensive view of how combination products are shaping the future of healthcare. Attendees will gain valuable insights into drug delivery device innovation, improving patient outcomes, and promoting sustainable practices in this dynamic field.
